MedTrace Logo

Growth of Healthy Term Infants Fed Formula Containing DHA-B

NCT02144402 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2015-08-04

No results posted yet for this study

Summary

The primary objective is to determine if the weight gain of healthy term infants fed a commercially available term infant formula supplemented with DHASCO® is similar to that of infants fed the same formula supplemented with a new product, DHASCO®-B.

Conditions

  • Growth
  • Tolerance
  • Infant Development

Interventions

OTHER

infant formula with DHASCO

OTHER

infant formula with DHASCO-B

Sponsors & Collaborators

  • Accelovance

    collaborator INDUSTRY

  • DSM Nutritional Products, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02144402 on ClinicalTrials.gov